We are live on ! Find out more
SM

Sabby Management Portfolio holdings

AUM $111M
1-Year Est. Return 74.4%
This Fund
S&P 500
This Quarter Est. Return
-41%
1 Year Est. Return
-74.4%
3 Year Est. Return
-95.55%
5 Year Est. Return
-99.44%
10 Year Est. Return
-99.5%
AUM
$147M
AUM Growth
-$523M
Cap. Flow
+$29.5M
Cap. Flow %
20.1%
Top 10 Hldgs %
64.77%
Holding
167
New
23
Increased
38
Reduced
54
Closed
36

Top Buys

Rank Stock Value
1
GEVO icon
Gevo
GEVO
+$20.1M
2
DOGZ icon
Dogness International Corp
DOGZ
+$8.37M
3
ONCO icon
Onconetix
ONCO
+$5.5M
4
MMAT
Meta Materials Inc. Common Stock
MMAT
+$3.83M
5
NEPT
Neptune Wellness Solutions Inc. Ordinary Shares
NEPT
+$3.81M

Top Sells

Rank Stock Value
1
CNTX icon
Context Therapeutics
CNTX
+$2.53M
2
HMCO
HumanCo Acquisition Corp. Class A Common Stock
HMCO
+$1.42M
3
USWS
U.S. Well Services, Inc. Class A Common Stock
USWS
+$1.07M
4
GYRE icon
Gyre Therapeutics
GYRE
+$871K
5
AGMH icon
AGM Group Holdings
AGMH
+$859K

Sector Composition

Rank Sector Weight
1 Miscellaneous 64.77%
2 Healthcare 12.59%
3 Materials 8.79%
4 Technology 5.45%
5 Consumer Discretionary 3.75%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
VTGN icon
26
PUT
VistaGen Therapeutics
VTGN
$10.5M
$1.14M 0.77%
115
+10
+10% +$353
NEPT
27
DELISTED
Neptune Wellness Solutions Inc. Ordinary Shares
NEPT
$1.05M 0.72%
+18,774
New +$3.81M
LFWD icon
28
ReWalk Robotics
LFWD
$20.2M
$994K 0.68%
12,589
-2,543
-17% -$216K
ATNM icon
29
CALL
Actinium Pharmaceuticals
ATNM
$44M
$986K 0.67%
2,049
+350
+21% +$1.99K
HMCO
30
DELISTED
HumanCo Acquisition Corp. Class A Common Stock
HMCO
$984K 0.67%
100,000
-144,684
-59% -$1.42M
GLBS icon
31
Globus Maritime Ltd
GLBS
$80.3M
$938K 0.64%
535,769
-178,394
-25% -$381K
BIVI icon
32
BioVie
BIVI
$17.3M
$910K 0.62%
6,274
+145
+2% +$43.5K
NBEV
33
DELISTED
NewAge, Inc. Common Stock (Delaware)
NBEV
$907K 0.62%
4,048,211
+91,485
+2% +$34.6K
AGMH icon
34
AGM Group Holdings
AGMH
$2.95M
$904K 0.62%
14,701
-8,859
-38% -$859K
ATNM icon
35
PUT
Actinium Pharmaceuticals
ATNM
$44M
$848K 0.58%
1,764
+293
+20% +$1.66K
EDVA
36
PUT
Endovia Health Sciences, Inc.
EDVA
$1.66M
$835K 0.57%
17
+1
+6% +$361
EVFM
37
PUT
DELISTED
Evofem Biosciences, Inc. Common Stock
EVFM
$787K 0.54%
6,962
+6,930
+21,656% +$11.4K
CING icon
38
Cingulate
CING
$73M
$766K 0.52%
2,186
-956
-30% -$330K
GEVO icon
39
CALL
Gevo
GEVO
$393M
$758K 0.52%
+3,226
New +$11.8K
XNTK icon
40
CALL
State Street SPDR NYSE Technology ETF
XNTK
$1.87B
$743K 0.51%
+100
New +$11.6K
VINC
41
DELISTED
Vincerx Pharma, Inc. Common Stock
VINC
$661K 0.45%
25,028
+8,666
+53% +$385K
HCDIZ
42
DELISTED
Harbor Custom Development, Inc. Warrant
HCDIZ
$648K 0.44%
1,727,769
-245,725
-12% -$102K
AGTC
43
DELISTED
Applied Genetic Technologies Corporation
AGTC
$625K 0.43%
811,973
-158,084
-16% -$141K
TCDA
44
PUT
DELISTED
Tricida, Inc. Common Stock
TCDA
$589K 0.4%
608
-621
-51% -$5.91K
ATOS icon
45
Atossa Therapeutics
ATOS
$25M
$572K 0.39%
34,987
+10,849
+45% +$171K
CRIS icon
46
Curis
CRIS
$2.72M
$482K 0.33%
1,225
+360
+42% +$150K
ASLN
47
DELISTED
ASLAN Pharmaceuticals Limited American Depositary Shares
ASLN
$446K 0.3%
22,500
-810
-3% -$18K
TANH icon
48
Tantech Holdings
TANH
$13.7M
$438K 0.3%
31
-1
-3% -$16.5K
IWM icon
49
iShares Russell 2000 ETF
IWM
$77.6B
$423K 0.29%
+2,500
New +$461K
PMCB icon
50
PUT
PharmaCyte Biotech
PMCB
$4.21M
$386K 0.26%
1,723
+1,036
+151% +$2.26K
1
2
3 4 5

Similar funds

IWA
Independent Wealth Advisors Cary, North Carolina $111M AUM
BFA
Ballast Financial Advisors West Chester, Pennsylvania $110M AUM
WPWM
Western Pacific Wealth Management Lake Forest, Illinois $111M AUM 26.64% 1-Year Est. Return
BCM
Beryl Capital Management Redondo Beach, California $111M AUM 205.39% 1-Year Est. Return
ZS
Zenith Solutions Philadelphia, Pennsylvania $110M AUM
KC
Karras Company Roy, Utah $110M AUM
FI
FinArc Investments Norwood, Massachusetts $110M AUM
CIM
Catalyst Investment Management Windham, New Hampshire $110M AUM

Sabby Management's Q2 2022 Portfolio in Review

As of Q2 2022, Sabby Management held 167 positions worth $147M, down 78% from $670M the previous quarter. Its ten largest holdings account for 65% of the portfolio.

Sabby Management deployed $29.5M of net new capital in Q2 2022, opening 23 new positions and adding to 38 existing holdings. Its largest new stake was Gevo: 5,486,831 shares worth $12.9M.

By sector, the portfolio is most concentrated in Miscellaneous at 65% of assets, down from 88% a quarter earlier, followed by Healthcare and Materials.

On the sell side, the largest reduction was HumanCo Acquisition Corp. Class A Common Stock, an estimated $1.42M trimmed.

  • Sabby Management's largest Q2 2022 buy was Gevo: 5,486,831 shares worth $12.9M.
  • Sabby Management added most to Canaan Creative in Q2 2022, an estimated $1.46M increase.
  • Sabby Management's biggest Q2 2022 reduction was HumanCo Acquisition Corp. Class A Common Stock, cutting an estimated $1.42M.
  • Sabby Management fully exited Context Therapeutics in Q2 2022, selling an estimated $2.53M.
  • Sabby Management's ten largest holdings make up 65% of its $147M portfolio in Q2 2022.
  • Sabby Management opened 23 new positions and closed 36 in Q2 2022.
  • Sabby Management's portfolio value fell 78% quarter-over-quarter to $147M.

Based on Sabby Management's 13F filing for Q2 2022, filed 15 Aug 2022.